FDA Approves New Drug for Ulcerative Colitis FDA Approves New Drug for Ulcerative Colitis
Mirikizumab (Omvoh) is the first IL-23 inhibitor to be approved in the United States for the treament of moderately to severely active ulcerative colitis.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news
More News: Drugs & Pharmacology | Gastroenterology | Inflammatory Bowel Disease | Ulcerative Colitis | USA Health